SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The filing discloses an amendment to the "Agreement and Plan of Merger, dated as of February 16, 2026, among Tenax Aerospace Acquisition, LLC, AIR and Transitory Air Sub LLC." The amendment modifies the definition of AIR Net Indebtedness to affect the share issuance calculation in the merger transaction. This is a material modification to an ongoing merger agreement that directly impacts deal economics and shareholder consideration.
View raw filing on EDGAR →The filing discloses results of a shareholder vote at an extraordinary annual meeting held on June 3, 2026, where shareholders approved an extension of the business combination deadline from June 6, 2026 to June 6, 2027. The disclosure includes specific voting outcomes (5,889,094 shares redeemed) and material financial consequences ($62.4M removed from trust account, $29M remaining), which directly affects the registrant's capital structure and timeline for completing its SPAC merger.
View raw filing on EDGAR →Snow Rothschild Acquisition Corp. completed its initial public offering on June 10, 2026, raising $200 million in gross proceeds from 20 million units at $10 per unit, plus an additional $26 million from partial exercise of the over-allotment option, and entered into multiple material agreements including an Underwriting Agreement, Warrant Agreement, Investment Management Trust Agreement, Registration Rights Agreement, and Private Placement Warrants Purchase Agreement.
View raw filing on EDGAR →The company issued 2,250,000 warrants to the Sponsor in a private placement simultaneously with IPO closing, priced at $1.00 per warrant ($2.25 million aggregate) and exercisable at $11.50 per share, relying on Section 4(a)(2) exemption.
View raw filing on EDGAR →Three directors—Marco Carrai, Paul Chellgren, and George Muñoz—were appointed to the board in connection with the IPO on June 8, 2026, and assigned to board committees.
View raw filing on EDGAR →The Company filed an updated Prospectus Supplement on June 12, 2026, authorizing the sale of up to $13.4 million of common shares through an at-the-market (ATM) offering program with JonesTrading. ATM offerings represent dilutive equity issuances that can be executed at management's discretion, which is a material event requiring disclosure under Item 3.02 (or Item 8.01 as here). The specific dollar amount and mechanism indicate a material capital-raising activity.
View raw filing on EDGAR →JAB Acquisition Corp I consummated its IPO on June 11, 2026, selling 17.25 million units at $10.00 per unit for $172.5 million in gross proceeds. The IPO involved execution of multiple material agreements including underwriting, warrant, rights, trust, registration rights, and private placement agreements, representing a material change in the company's capital structure.
View raw filing on EDGAR →JAB Acquisition Corp I completed a private placement of 260,000 units to the Sponsor at $10.00 per unit for $2.6 million in proceeds under Section 4(a)(2) of the Securities Act. The units consist of Class A Ordinary Shares, warrants, and rights to receive additional shares upon business combination completion.
View raw filing on EDGAR →JAB Acquisition Corp I appointed three independent directors—Luisa Ingargiola, Kyle Miller, and David Pfeffer—to the board of directors in connection with the company's IPO on June 11, 2026.
View raw filing on EDGAR →This exhibit is a patent asset purchase agreement dated June 5, 2026, between Tianjin Qianli Culture Media Co., Ltd. (Party A) and Tianjin Information Sea Information Technology Co., Ltd. (Party B, a wholly owned subsidiary of DTSS). The agreement contemplates DTSS issuing Class A ordinary shares valued at RMB 7,000,000 (approximately USD equivalent) to two designated natural persons (Yang Zhaobing and Lü Hongwei) as consideration for the patent transfer. The agreement explicitly caps the issuance at 19.99% of DTSS's pre-issuance shares to avoid triggering Nasdaq's 20% shareholder approval rule, and each recipient is capped at 9.99% beneficial ownership. This is a classic dilutive equity issuance—unregistered restricted securities issued to third parties in exchange for assets, structured to avoid shareholder approval thresholds. The transaction is material to investors as it represents a significant equity dilution and capital raise mechanism.
View raw filing on EDGAR →The 6-K discloses issuance of a $2.0 million convertible note (the "Third Note") on June 5, 2026, convertible into Class B Ordinary Shares at $920 per $1,000 principal, plus a conditional commitment to issue an additional $11.0 million Fourth Note upon satisfaction of registration and Nasdaq compliance conditions. This is an unregistered private placement of convertible securities under Section 4(a)(2) and Regulation D, creating dilution to existing shareholders upon conversion. The amendment to the Securities Purchase Agreement restructures the facility and adds new issuance tranches, materially affecting the capital structure.
View raw filing on EDGAR →The company approved the 2026 Executive Compensation Plan on February 26, 2026, increasing base salaries by 5% for CEO Steven M. Foster ($420,000), CFO Kevin Williamson ($330,750), and COO Richard Ginn ($304,500), and modified annual bonus opportunities. Additionally, the company amended Richard Ferrari's consulting agreement as Executive Chairman, extending his term through May 6, 2027 at $180,000 annually.
View raw filing on EDGAR →This disclosure reports the consummation of a $230 million IPO and concurrent $6 million private placement of warrants by a SPAC (special purpose acquisition company). While the IPO itself is a material capital-raising event affecting the registrant's financial position, it does not fit cleanly into the standard 8-K taxonomy—it is neither a traditional earnings release, M&A activity, nor a dilutive issuance in the sense of a distressed equity raise. The event is material to investors but best classified as "other_material" given the SPAC structure and the combination of public and private securities offerings.
View raw filing on EDGAR →The filing discloses a business combination transaction between RAAQ and IQM Finland Oy, with the Business Combination Agreement entered into on February 22, 2026, and the Registration Statement declared effective on June 5, 2026. The Item 8.01 disclosure announces the appointment of Barbara Venneman to IQM's Board and references the pending extraordinary general meeting of RAAQ shareholders to vote on the Transaction. This is a material acquisition/change of control event that will result in IQM becoming a publicly traded company through the SPAC merger.
View raw filing on EDGAR →The filing discloses completion of a disposition of a material asset—the Sheraton Mission Valley hotel in San Diego—for approximately $45.3 million in cash. This is a completed asset sale by a wholly owned subsidiary of the registrant, disclosed under Item 2.01 (Completion of Acquisition or Disposition of Assets), and represents a material reduction in the company's real estate portfolio that would affect investor assessment of asset base and liquidity.
View raw filing on EDGAR →Vale received a shareholder request from Previ (a major shareholder) to call an Extraordinary General Meeting to remove Board member Daniel André Stieler, nominate José Mauricio Pereira Coelho as a replacement, and elect a new Chairman (with Previ supporting Manuel Lino Silva de Sousa Oliveira). This is a governance event involving potential removal and appointment of directors and board leadership, which would materially affect investor assessment of the company's governance structure and strategic direction.
View raw filing on EDGAR →Pampa Energía discloses an upgrade of its long-term foreign and local currency credit ratings from "B-" to "B" with stable outlook by S&P. While this is a material event affecting investor perception of the company's creditworthiness and financial condition, it does not fit neatly into the specific financial event categories (debt_issuance, covenant_breach, material_impairment, etc.). The rating upgrade is a financial event but represents a positive development in the company's credit profile rather than a discrete transaction or accounting matter, warranting classification as other_material.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Live Nation's June 11, 2026 annual meeting, including election of 12 directors, an advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor. The filing presents detailed voting tallies for all three proposals, which is the quintessential content of Item 5.07 shareholder vote results disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →This Item 5.07 disclosure presents the complete results of Etsy's 2026 Annual Meeting of Stockholders held on June 9, 2026, including voting outcomes on five proposals: election of Class II directors (M. Michele Burns, Josh Silverman, and Fred Wilson), advisory approval of named executive officer compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of an amendment to the 2024 Equity Incentive Plan, and rejection of a stockholder proposal on majority voting. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core disclosure required by Item 5.07.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from CapsoVision's 2026 Annual Meeting held on June 11, 2026. The filing reports voting outcomes for two proposals: (1) re-election of three Class I Directors (Joanne Imperial, Wen-Herng King, and Michele Harari), and (2) ratification of Baker Tilly US, LLP as independent auditor. Both proposals passed with overwhelming support. This is a routine but material Item 5.07 disclosure required by SEC rules.
View raw filing on EDGAR →The filing discloses the election of David Hult as a director of OPENLANE, Inc., effective June 12, 2026, following a Board decision on June 9, 2026 to increase the Board size to ten directors. This is a clear executive appointment event. Mr. Hult brings significant automotive industry experience, having recently served as Executive Chairman of Asbury Automotive Group (NYSE: ABG) and previously as President and CEO of that company. The appointment of a seasoned executive to the Board is material to investors assessing the Company's governance and strategic direction.
View raw filing on EDGAR →Dare Bioscience held a stockholder meeting on June 11, 2026, with voting results on eight proposals including director elections, auditor ratification, say-on-pay approval, and an amendment to the 2022 Stock Incentive Plan increasing available shares by 1,500,000.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Q2 Holdings' 2026 annual meeting held on June 10, 2026. The filing reports voting outcomes on three proposals: election of seven directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, and the disclosure includes vote counts and percentages as required by Item 5.07.
View raw filing on EDGAR →Western Midstream Operating, LP completed the acquisition of Brazos Delaware II, LLC for approximately $1.6 billion in cash and WES common units on June 11, 2026, pursuant to a Membership Interest Purchase Agreement dated May 6, 2026.
View raw filing on EDGAR →Western Midstream Partners, LP consummated the acquisition of Brazos Delaware II, LLC for approximately $1.6 billion in cash and equity consideration (19.4 million common units) on June 11, 2026, pursuant to a Membership Interest Purchase Agreement dated May 6, 2026.
View raw filing on EDGAR →Invesco Mortgage Capital issued a press release on June 12, 2026 disclosing preliminary financial data as of May 31, 2026, including book value, portfolio composition, liquidity, and leverage metrics. The preliminary financial disclosure is material to investors assessing the mortgage REIT's portfolio performance and dividend sustainability.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Build-A-Bear Workshop's 2026 Annual Meeting held on June 11, 2026. The filing presents tabulated voting results for three proposals: election of three directors (James A Goldman, Narayan Iyengar, and Lesli Rotenberg), ratification of Ernst & Young LLP as independent accountants, and advisory approval of executive compensation. All three proposals passed by requisite majorities. This is a standard Item 5.07 disclosure of shareholder meeting outcomes, which is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →The filing discloses Voin Todorovic's promotion to the additional role of Chief Administrative Officer effective June 11, 2026, while continuing as Chief Financial Officer. Although the disclosure also includes compensatory arrangements (base salary of $500,000 and target bonus of 70% of base pay), the principal action is the appointment to a new executive role. The promotion of an existing CFO to dual CFO/CAO responsibilities is material to investors assessing executive leadership structure.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual General Meeting held on June 11, 2026. The filing reports the outcomes of fourteen resolutions including director elections (Resolutions 1-7), approval of the Directors' Remuneration Report (Resolution 8), say-on-pay votes (Resolutions 9-10), auditor ratification (Resolution 11), and share issuance authorizations (Resolutions 13-14), with detailed vote tallies for each resolution. This is a quintessential Item 5.07 disclosure of shareholder meeting results.
View raw filing on EDGAR →BioCardia received a Nasdaq delisting notice on April 10, 2026 for failing to maintain the $2.5 million minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). Although the company claims to have regained compliance through an ATM offering that raised $4.9 million in net proceeds, Nasdaq retains ongoing monitoring authority and explicitly warns that "if at the time of its next periodic report the Company does not evidence compliance, it may be subject to delisting." This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →Smith Micro entered into inducement letter agreements to issue 487,349 unregistered Common Stock warrants at an exercise price of $3.80 per share in exchange for warrant holders exercising existing warrants at $3.35 per share, raising approximately $1.6 million in gross proceeds under Section 4(a)(2) and Rule 506 exemptions.
View raw filing on EDGAR →Capstone entered into an Amended and Restated Common Stock Purchase Agreement on June 11, 2026, establishing an equity line of credit permitting the sale of up to $20,000,000 in newly issued common stock to an accredited investor at 97% of VWAP, with up to 4,975,197 registered shares potentially dilutive to existing shareholders.
View raw filing on EDGAR →The disclosure centers on a material change to Ms. Conn's compensation arrangement as CFO: her transition to part-time status effective June 29, 2026, with a corresponding salary adjustment to reflect her reduced work schedule. While the filing is captioned Item 5.02 (which covers departures, appointments, and compensation), the principal action disclosed is a compensatory arrangement modification rather than a departure (she remains CFO) or appointment (no new officer is being named). The salary adjustment tied to the role change is the material event.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the June 11, 2026 Annual Meeting of Stockholders. The filing reports the vote tallies for two proposals: election of seven directors and ratification of Deloitte & Touche LLP as independent auditor. All director nominees were duly elected, and the auditor appointment was ratified. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms the composition of the board and auditor for the fiscal year.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Generac's 2026 annual meeting, covering three proposals: election of directors (Marcia J. Avedon, Bennett J. Morgan, Dominick P. Zarcone), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of executive compensation. The tabulated voting results with For/Against/Abstain/Broker Non-Vote columns are the hallmark of Item 5.07 disclosure and are material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of TG Therapeutics' 2026 Annual Meeting held on June 11, 2026. The filing presents detailed voting results for three proposals: election of six directors, ratification of KPMG LLP as independent auditor, and an advisory vote on named executive officer compensation. The disclosure is material as it documents shareholder approval of board composition and auditor ratification, though notably Proposal 3 (say-on-pay) was not approved, with 48.9 million votes against versus 31.9 million for.
View raw filing on EDGAR →The filing discloses termination of an Equity Distribution Agreement (Sales Agreement) dated July 28, 2023, which provided for up to $450 million in aggregate gross sales of common stock through sales agents and forward sellers. While the termination itself is routine (triggered by expiration of the underlying shelf registration), the agreement's material size and the company's loss of this financing flexibility warrant disclosure. The termination is not a covenant breach, M&A activity, or other more specific event type, making "other_material" the most appropriate classification.
View raw filing on EDGAR →Genprex received a formal delisting notice from Nasdaq on June 10, 2026, for failure to maintain the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company is ineligible for a compliance period due to a reverse stock split effected on October 21, 2025, and must request a hearing before a Nasdaq Hearings Panel to avoid delisting.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the certified results of Everpure's June 10, 2026 annual meeting of stockholders. The filing presents voting outcomes for three proposals: election of three Class II directors (Andrew Brown, John Colgrove, and Roxanne Taylor), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) are the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →The filing discloses a change in the Company's independent registered public accounting firm: Stephano Slack LLC was dismissed effective June 12, 2026, and replaced by Sadler, Gibb & Associates, LLC on the same date. While the prior auditor's report contained an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern, the primary event disclosed under Item 4.01 is the auditor change itself. This is material as it affects investor confidence in financial reporting and audit quality.
View raw filing on EDGAR →DATZ World Holdings Corp. completed a material merger on June 8, 2026, acquiring RagingBull.com, LLC through a subsidiary merger in exchange for 15,000,000 newly issued shares, resulting in a change of control with RagingBull Holders obtaining approximately 95% beneficial ownership post-merger, a corporate name change, and a reverse stock split.
View raw filing on EDGAR →The registrant issued 15,000,000 unregistered shares of Common Stock to RagingBull Holders in connection with the merger, relying on Section 4(2) and Rule 506 exemptions, materially diluting existing shareholder equity and voting power.
View raw filing on EDGAR →Item 5.02 incorporates Item 1.01 by reference, indicating material changes to executive roles, compensation, or governance in connection with the merger and change of control, though the specific nature of these changes cannot be determined without access to the full Item 1.01 disclosure.
View raw filing on EDGAR →The Company issued 865,903 unregistered shares of common stock in exchange for Series B Preferred Stock held by Streeterville Capital, LLC pursuant to Section 3(a)(9) exemption. This is a dilutive equity issuance that materially increases the common share count and would affect a reasonable investor's assessment of ownership dilution and voting power, particularly given the substantial number of shares issued relative to a small-cap issuer.
View raw filing on EDGAR →This Item 1.01 discloses a material amendment to an Agreement and Plan of Merger between AI Technology Group Inc., AVM Biotechnology Inc., and Biomed 360 Solutions Corp. The June 4, 2026 amendment modifies critical merger terms including investment obligations (tranches totaling over $50 million), conversion rates for convertible loans, and extends the Closing Date from July 26, 2026 to December 31, 2026. These are substantive changes to a material acquisition transaction that would significantly affect investor assessment of the merger's timing, financing structure, and likelihood of completion.
View raw filing on EDGAR →Edible Garden AG entered into a $12 million debt financing agreement secured by promissory notes with restrictive covenants. The transaction was disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and incorporated by reference in Item 2.03 (Creation of a Direct Financial Obligation).
View raw filing on EDGAR →The filing discloses Item 5.07 results from Research Frontiers' Annual Meeting of Stockholders held June 11, 2026, reporting voting outcomes on four proposals: election of Darryl Daigle to the Board (6,614,329 shares in favor), ratification of CohnReznick LLP as independent accountants (19,445,284 shares in favor), non-binding approval of executive compensation (7,016,800 shares in favor), and frequency of say-on-pay votes (6,575,519 shares favoring annual frequency). This is a standard shareholder vote results disclosure material to investors' understanding of governance and compensation approval.
View raw filing on EDGAR →The filing discloses conversion of approximately $97.5 million in convertible notes into 7,649,523 shares of Class A Ordinary Common Stock on June 11, 2026, pursuant to Item 3.02. The Conversion Shares were issued unregistered under Section 4(a)(2) and Regulation D exemptions, representing a significant dilutive equity issuance that would materially affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →Michael Amoroso resigned as a member of the Board of Directors of Abeona Therapeutics Inc. effective immediately on June 11, 2026, and also resigned from the Nominating and Corporate Governance Committee. This is a clear executive departure disclosed under Item 5.02, and board departures are material events affecting the registrant's governance structure and investor assessment.
View raw filing on EDGAR →SharonAI announced a six-year strategic compute collaboration with NVIDIA Corporation under a Master Cloud Services Agreement with a contract value of up to $4.88 billion, dated June 8, 2026. This represents a material commercial arrangement that would substantially affect the registrant's revenue, capital requirements, and operational obligations. The filing extensively discusses performance risks, financing needs, and termination provisions, all hallmarks of a material business engagement requiring disclosure under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →